Logo image of BMI

BADGER METER INC (BMI) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:BMI - US0565251081 - Common Stock

177.21 USD
+0.3 (+0.17%)
Last: 11/28/2025, 10:45:07 AM
Fundamental Rating

7

Overall BMI gets a fundamental rating of 7 out of 10. We evaluated BMI against 123 industry peers in the Electronic Equipment, Instruments & Components industry. BMI gets an excellent profitability rating and is at the same time showing great financial health properties. BMI is valied quite expensively at the moment, while it does show a decent growth rate. These ratings could make BMI a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year BMI was profitable.
In the past year BMI had a positive cash flow from operations.
In the past 5 years BMI has always been profitable.
Each year in the past 5 years BMI had a positive operating cash flow.
BMI Yearly Net Income VS EBIT VS OCF VS FCFBMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

BMI has a better Return On Assets (14.19%) than 92.68% of its industry peers.
With an excellent Return On Equity value of 19.75%, BMI belongs to the best of the industry, outperforming 89.43% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 16.43%, BMI belongs to the top of the industry, outperforming 92.68% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BMI is significantly above the industry average of 9.11%.
The last Return On Invested Capital (16.43%) for BMI is above the 3 year average (15.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 14.19%
ROE 19.75%
ROIC 16.43%
ROA(3y)13.08%
ROA(5y)12.25%
ROE(3y)17.86%
ROE(5y)16.46%
ROIC(3y)15.23%
ROIC(5y)14.23%
BMI Yearly ROA, ROE, ROICBMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of BMI (15.40%) is better than 91.87% of its industry peers.
BMI's Profit Margin has improved in the last couple of years.
BMI has a Operating Margin of 19.93%. This is amongst the best in the industry. BMI outperforms 97.56% of its industry peers.
BMI's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 41.26%, BMI is in the better half of the industry, outperforming 69.11% of the companies in the same industry.
In the last couple of years the Gross Margin of BMI has remained more or less at the same level.
Industry RankSector Rank
OM 19.93%
PM (TTM) 15.4%
GM 41.26%
OM growth 3Y7.03%
OM growth 5Y5.49%
PM growth 3Y7.84%
PM growth 5Y6.34%
GM growth 3Y-0.7%
GM growth 5Y0.68%
BMI Yearly Profit, Operating, Gross MarginsBMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BMI is creating some value.
Compared to 1 year ago, BMI has more shares outstanding
The number of shares outstanding for BMI has been increased compared to 5 years ago.
There is no outstanding debt for BMI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BMI Yearly Shares OutstandingBMI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BMI Yearly Total Debt VS Total AssetsBMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 14.18 indicates that BMI is not in any danger for bankruptcy at the moment.
The Altman-Z score of BMI (14.18) is better than 93.50% of its industry peers.
BMI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 14.18
ROIC/WACC1.79
WACC9.19%
BMI Yearly LT Debt VS Equity VS FCFBMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

BMI has a Current Ratio of 3.22. This indicates that BMI is financially healthy and has no problem in meeting its short term obligations.
BMI has a better Current ratio (3.22) than 67.48% of its industry peers.
A Quick Ratio of 2.23 indicates that BMI has no problem at all paying its short term obligations.
BMI's Quick ratio of 2.23 is fine compared to the rest of the industry. BMI outperforms 62.60% of its industry peers.
Industry RankSector Rank
Current Ratio 3.22
Quick Ratio 2.23
BMI Yearly Current Assets VS Current LiabilitesBMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.63% over the past year.
The Earnings Per Share has been growing by 21.16% on average over the past years. This is a very strong growth
Looking at the last year, BMI shows a quite strong growth in Revenue. The Revenue has grown by 12.11% in the last year.
Measured over the past years, BMI shows a quite strong growth in Revenue. The Revenue has been growing by 14.25% on average per year.
EPS 1Y (TTM)16.63%
EPS 3Y26.69%
EPS 5Y21.16%
EPS Q2Q%10.19%
Revenue 1Y (TTM)12.11%
Revenue growth 3Y17.83%
Revenue growth 5Y14.25%
Sales Q2Q%13.06%

3.2 Future

BMI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.65% yearly.
BMI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.05% yearly.
EPS Next Y14.96%
EPS Next 2Y13.85%
EPS Next 3Y11.31%
EPS Next 5Y11.65%
Revenue Next Year12.6%
Revenue Next 2Y10.45%
Revenue Next 3Y8.85%
Revenue Next 5Y9.05%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BMI Yearly Revenue VS EstimatesBMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
BMI Yearly EPS VS EstimatesBMI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 37.70, the valuation of BMI can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as BMI.
BMI's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.15.
Based on the Price/Forward Earnings ratio of 32.32, the valuation of BMI can be described as expensive.
BMI's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.12, BMI is valued at the same level.
Industry RankSector Rank
PE 37.7
Fwd PE 32.32
BMI Price Earnings VS Forward Price EarningsBMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BMI's Enterprise Value to EBITDA is on the same level as the industry average.
69.11% of the companies in the same industry are more expensive than BMI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 31.4
EV/EBITDA 23.48
BMI Per share dataBMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
BMI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.52
PEG (5Y)1.78
EPS Next 2Y13.85%
EPS Next 3Y11.31%

6

5. Dividend

5.1 Amount

BMI has a yearly dividend return of 0.95%, which is pretty low.
Compared to an average industry Dividend Yield of 2.44, BMI pays a better dividend. On top of this BMI pays more dividend than 83.74% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, BMI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.95%

5.2 History

The dividend of BMI is nicely growing with an annual growth rate of 13.80%!
BMI has paid a dividend for at least 10 years, which is a reliable track record.
BMI has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)13.8%
Div Incr Years18
Div Non Decr Years18
BMI Yearly Dividends per shareBMI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

BMI pays out 30.10% of its income as dividend. This is a sustainable payout ratio.
BMI's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP30.1%
EPS Next 2Y13.85%
EPS Next 3Y11.31%
BMI Yearly Income VS Free CF VS DividendBMI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
BMI Dividend Payout.BMI Dividend Payout, showing the Payout Ratio.BMI Dividend Payout.PayoutRetained Earnings

BADGER METER INC

NYSE:BMI (11/28/2025, 10:45:07 AM)

177.21

+0.3 (+0.17%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-21 2025-10-21/bmo
Earnings (Next)01-29 2026-01-29/amc
Inst Owners99.93%
Inst Owner Change1.8%
Ins Owners0.51%
Ins Owner Change0%
Market Cap5.22B
Revenue(TTM)901.14M
Net Income(TTM)138.78M
Analysts76
Price Target225.55 (27.28%)
Short Float %6.55%
Short Ratio5.03
Dividend
Industry RankSector Rank
Dividend Yield 0.95%
Yearly Dividend1.22
Dividend Growth(5Y)13.8%
DP30.1%
Div Incr Years18
Div Non Decr Years18
Ex-Date11-21 2025-11-21 (0.4)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.02%
Min EPS beat(2)-7.6%
Max EPS beat(2)3.55%
EPS beat(4)2
Avg EPS beat(4)2.98%
Min EPS beat(4)-7.6%
Max EPS beat(4)21.92%
EPS beat(8)5
Avg EPS beat(8)4.65%
EPS beat(12)8
Avg EPS beat(12)6.34%
EPS beat(16)11
Avg EPS beat(16)6.98%
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-0.51%
Max Revenue beat(2)0.62%
Revenue beat(4)2
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-0.51%
Max Revenue beat(4)0.62%
Revenue beat(8)4
Avg Revenue beat(8)1.08%
Revenue beat(12)8
Avg Revenue beat(12)2.82%
Revenue beat(16)11
Avg Revenue beat(16)2.84%
PT rev (1m)-4.93%
PT rev (3m)-5.51%
EPS NQ rev (1m)2.38%
EPS NQ rev (3m)1.54%
EPS NY rev (1m)1.03%
EPS NY rev (3m)0.42%
Revenue NQ rev (1m)-0.26%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)0.26%
Revenue NY rev (3m)0.16%
Valuation
Industry RankSector Rank
PE 37.7
Fwd PE 32.32
P/S 5.8
P/FCF 31.4
P/OCF 28.86
P/B 7.43
P/tB 15.19
EV/EBITDA 23.48
EPS(TTM)4.7
EY2.65%
EPS(NY)5.48
Fwd EY3.09%
FCF(TTM)5.64
FCFY3.18%
OCF(TTM)6.14
OCFY3.47%
SpS30.58
BVpS23.84
TBVpS11.67
PEG (NY)2.52
PEG (5Y)1.78
Graham Number50.21
Profitability
Industry RankSector Rank
ROA 14.19%
ROE 19.75%
ROCE 21.77%
ROIC 16.43%
ROICexc 21.75%
ROICexgc 51.26%
OM 19.93%
PM (TTM) 15.4%
GM 41.26%
FCFM 18.45%
ROA(3y)13.08%
ROA(5y)12.25%
ROE(3y)17.86%
ROE(5y)16.46%
ROIC(3y)15.23%
ROIC(5y)14.23%
ROICexc(3y)23.61%
ROICexc(5y)20.43%
ROICexgc(3y)41.01%
ROICexgc(5y)36.17%
ROCE(3y)20.17%
ROCE(5y)18.85%
ROICexgc growth 3Y15.78%
ROICexgc growth 5Y16.08%
ROICexc growth 3Y21.65%
ROICexc growth 5Y15.12%
OM growth 3Y7.03%
OM growth 5Y5.49%
PM growth 3Y7.84%
PM growth 5Y6.34%
GM growth 3Y-0.7%
GM growth 5Y0.68%
F-Score5
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 43.31%
Cap/Sales 1.63%
Interest Coverage 250
Cash Conversion 84.78%
Profit Quality 119.84%
Current Ratio 3.22
Quick Ratio 2.23
Altman-Z 14.18
F-Score5
WACC9.19%
ROIC/WACC1.79
Cap/Depr(3y)34.99%
Cap/Depr(5y)33.03%
Cap/Sales(3y)1.43%
Cap/Sales(5y)1.55%
Profit Quality(3y)111.64%
Profit Quality(5y)126.18%
High Growth Momentum
Growth
EPS 1Y (TTM)16.63%
EPS 3Y26.69%
EPS 5Y21.16%
EPS Q2Q%10.19%
EPS Next Y14.96%
EPS Next 2Y13.85%
EPS Next 3Y11.31%
EPS Next 5Y11.65%
Revenue 1Y (TTM)12.11%
Revenue growth 3Y17.83%
Revenue growth 5Y14.25%
Sales Q2Q%13.06%
Revenue Next Year12.6%
Revenue Next 2Y10.45%
Revenue Next 3Y8.85%
Revenue Next 5Y9.05%
EBIT growth 1Y19.1%
EBIT growth 3Y26.12%
EBIT growth 5Y20.53%
EBIT Next Year36.93%
EBIT Next 3Y16.39%
EBIT Next 5Y15.08%
FCF growth 1Y83.29%
FCF growth 3Y20.76%
FCF growth 5Y14.2%
OCF growth 1Y77.62%
OCF growth 3Y21%
OCF growth 5Y13.95%

BADGER METER INC / BMI FAQ

What is the fundamental rating for BMI stock?

ChartMill assigns a fundamental rating of 7 / 10 to BMI.


What is the valuation status of BADGER METER INC (BMI) stock?

ChartMill assigns a valuation rating of 3 / 10 to BADGER METER INC (BMI). This can be considered as Overvalued.


Can you provide the profitability details for BADGER METER INC?

BADGER METER INC (BMI) has a profitability rating of 9 / 10.


What are the PE and PB ratios of BADGER METER INC (BMI) stock?

The Price/Earnings (PE) ratio for BADGER METER INC (BMI) is 37.7 and the Price/Book (PB) ratio is 7.43.


Can you provide the dividend sustainability for BMI stock?

The dividend rating of BADGER METER INC (BMI) is 6 / 10 and the dividend payout ratio is 30.1%.